NANCY ROE: Open Payments
NPI 1124680673 · VALDOSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,857 in 125 payments from 19 companies in 2025. Trend: 2023 $652 · 2024 $1,524 · 2025 $2,857
Food & beverage: $2,753Education: $104
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $715 |
| Madrigal Pharmaceuticals | 17 | $483 |
| Janssen Biotech, Inc. | 15 | $392 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $262 |
| Ardelyx, Inc. | 10 | $208 |
| Aimmune Therapeutics, Inc. | 6 | $119 |
| Phathom Pharmaceuticals, Inc. | 11 | $116 |
| PFIZER INC. | 5 | $100 |
| GENZYME CORPORATION | 2 | $74 |
| Regeneron Healthcare Solutions, Inc. | 2 | $71 |
Products named: REZDIFFRA, TREMFYA, RINVOQ, LINZESS, ENTYVIO, IBSRELA, SKYRIZI, DUPIXENT.
Industry payments across GA — which companies pay providers there.
